LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 26.8% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 3,452,178 shares of the company’s stock after buying an additional 729,794 shares during the quarter. Geode Capital Management LLC’s holdings in LifeStance Health Group were worth $24,170,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of LFST. Townsquare Capital LLC acquired a new stake in LifeStance Health Group in the third quarter valued at $73,000. Park Edge Advisors LLC purchased a new position in shares of LifeStance Health Group in the 3rd quarter valued at about $73,000. CIBC Asset Management Inc acquired a new stake in shares of LifeStance Health Group in the second quarter valued at about $53,000. Algert Global LLC purchased a new stake in LifeStance Health Group during the second quarter worth about $57,000. Finally, Victory Capital Management Inc. grew its position in LifeStance Health Group by 27.0% during the second quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock worth $71,000 after buying an additional 3,063 shares during the period. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a research note on Monday, December 16th. Barclays lifted their price objective on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $8.70.

LifeStance Health Group Stock Up 0.7 %

Shares of NASDAQ LFST opened at $7.49 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The firm’s 50-day moving average is $7.23 and its two-hundred day moving average is $6.44. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $9.20. The company has a market capitalization of $2.87 billion, a PE ratio of -28.81 and a beta of 1.28.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.05. The firm had revenue of $312.70 million for the quarter, compared to analyst estimates of $302.25 million. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. LifeStance Health Group’s revenue was up 18.9% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.17) EPS. Equities analysts anticipate that LifeStance Health Group, Inc. will post -0.2 EPS for the current fiscal year.

Insider Activity at LifeStance Health Group

In other news, Director Robert Bessler sold 75,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $565,500.00. Following the completion of the transaction, the director now owns 1,424,447 shares of the company’s stock, valued at $10,740,330.38. The trade was a 5.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 6.60% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.